Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Stock Information for Esports Entertainment Group Inc.
Loading
Please wait while we load your information from QuoteMedia.